Finally, a recent study suggested that although prasugrel significantly reduces thrombotic events in patients with ACS undergoing PCI because of its superior antiplatelet potency compared with ...

Common antiplatelet medications include aspirin, which inhibits the enzyme cyclooxygenase-1 (COX-1), and clopidogrel, which ...

No writing assistance was utilized in the production of this manuscript. The combined use of antiplatelet drugs acting through different mechanisms is important in antithrombotic treatment of ...

A new meta-analysis examines the effects of dual antiplatelet therapy after thrombolysis in minor stroke patients. Findings ...

A deescalation strategy involving switching from ticagrelor to clopidogrel in patients with acute myocardial infarction (AMI) ...

A LANDMARK Australian-New Zealand study of 586 patients with spontaneous coronary artery dissection (SCAD), has identified ...

With no differences between single or dual antiplatelet therapy or anticoagulants at 6 months, an RCT is warranted for clarity.

The following is a summary of “Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: Meta-analysis of Randomized Trials,” published in the January 2025 issue of ...

More potent DAPT strategies and oral anticoagulation were tied to worse outcomes and should be avoided, researchers say.

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Guidelines continue to recommend standard dual antiplatelet therapy while endorsing de-escalating therapy and ...